CIBC Innovation Banking provides growth capital to EnsoData. * Business Wire * May 12, 2026 * 0 MADISON, Wis.-(BUSINESS WIRE)-May 12, 2026- CIBC Innovation Banking announced today that it has provided growth capital financing for EnsoData, a leading provider of AI-powered software solutions for sleep medicine. EnsoData is advancing sleep medicine through AI-powered, FDA-cleared solutions that help simplify diagnosis and expand access to care. Its flagship product, EnsoHST, is a clinically proven, multi-night home sleep testing solution that uses a simple wearable device and mobile app to deliver fast, clinically reliable results. By automating analysis and removing operational friction, EnsoData enables clinicians to expand capacity, accelerate diagnosis, and improve patient outcomes. "This facility from CIBC Innovation Banking enables EnsoData to expand access to the sleep care pathway today, while accelerating our investment in AI-driven innovations that will shape the future of diagnostics across multiple clinical domains," said Matt Dobereiner, CFO of EnsoData. "CIBC Innovation Banking is very glad to support EnsoData's growth and continued adoption among sleep medicine professionals," said Andrew Schwartz, Managing Director, CIBC Innovation Banking. "EnsoData is at the exciting intersection of leveraging AI and machine-learning technology to improve access for patients to the care pathway." About CIBC Innovation Banking CIBC Innovation Banking has 25 years of specialized experience in growth-stage tech and life science companies across North America - a longer track record than most banks. CIBC Innovation Banking now has over $11 billion in funds managed including life sciences, health care, cleantech companies, investors, and entrepreneurs, and has assisted over 700 venture and private equity-backed businesses over the past six and a half years. The bank operates out of 14 global locations in San Francisco, Menlo Park, New York, Toronto, London, Austin, Boston, Chicago, Seattle, Vancouver, Montreal, Atlanta, Reston, and Durham. Connect with us today to start the conversation. Innovationbanking.cibc.com About EnsoData EnsoData is a healthcare technology company advancing sleep medicine through artificial intelligence. Its solutions support the full sleep care continuum, from diagnosis through long-term patient management, enabling clinicians to improve efficiency and expand access to care. EnsoData is also exploring applications across additional clinical areas. To date, EnsoData's technology has supported the care of more than 2.9 million patients. https://ensodata.com Katarina Milicevic,[email protected], 416-362-3458 KEYWORD: WISCONSIN UNITED STATES NORTH AMERICA CANADA INDUSTRY KEYWORD: BANKING TECHNOLOGY PROFESSIONAL SERVICES HEALTH VENTURE CAPITAL HEALTH TECHNOLOGY APPS/APPLICATIONS SOFTWARE ARTIFICIAL INTELLIGENCE MOBILE/WIRELESS FINANCE PUB: 05/12/2026 07:00 AM/DISC: 05/12/2026 07:00 AM

EnsoData has announced a collaboration with Takeda to jointly develop and validate AI-based polysomnography (PSG) algorithms to support more accurate and scalable diagnosis of narcolepsy type 1 (NT1).

MADISON, Wis. - August 21, 2025 - Today, EnsoData, a pioneer in healthcare AI, announces a collaboration with Takeda to jointly develop and validate AI-based polysomnography (PSG) algorithms to support more accurate and scalable diagnosis of narcolepsy type 1 (NT1).